Tuberous sclerosis complex (TSC) is a genetic disorder affecting cellular differentiation, proliferation, and migration early in development, resulting in a variety of hamartomatous lesions effecting vital organs.
Prevalance of Tuberous sclerosis is reported to be less than 1 in 10,000 of population. Tuberous sclerosis is listed as a "rare disease" by the Office of Rare Diseases (ORD)
Because TSC is a lifelong condition, individuals need to be regularly monitored by a doctor to make sure they are receiving the best possible treatments.
Prevention of the worse aspects of TSC amongst neonates including: Epilepsy, ASD, Intellectual impairment, SUDEP, skin rash, kidney & lung disease etc. is one of the objectives of TSC research.